Skip to main content
SpringerLink
Log in

Finasteride: oral therapy preserves crowning glory?

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Andersson S, Berman DM, Jenkins EP, et al. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 1991 Nov 14; 354: 159–61

    Article  PubMed  CAS  Google Scholar 

  2. Olsen EA. Androgenetic alopecia. In: Disorders of hair growth: diagnosis and treatment. New York: McGraw-Hill, Inc., 1993: 257–83

    Google Scholar 

  3. McClellan KJ, Markham A. Finasteride: a review of its use in male pattern hair loss. Drugs 1999 Jan; 57(1): 111–26

    Article  PubMed  CAS  Google Scholar 

  4. Pharmacia & Upjohn. Regaine topical solution. UK Data Sheet

  5. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998; 39 (4 Pt 1): 578–89

    Article  PubMed  CAS  Google Scholar 

  6. Waldstreicher J, Thiboutot D, Dunlap F, et al. The effects of finasteride in men with frontal male pattern hair loss. Aust J Dermatol 1997; 38 (Suppl. 2): 101–2

    Google Scholar 

  7. Merck & Co. Inc. Worldwide Product Circular: Propecia (finasteride, MSD). USA, 1997

  8. Merck & Co. Propecia (finasteride) prescribing information. West Point, PA, USA, 1997

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finasteride: oral therapy preserves crowning glory?. Drugs Ther. Perspect 13, 1–4 (1999). https://doi.org/10.2165/00042310-199913100-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199913100-00001

Keywords

Search

Navigation